24 June 2022

Champalimaud Foundation team distinguished with the "Faz Ciência" 2022 Prize

The BALANCE project, from the Cancer and Stem Cell Biology Lab at Champalimaud Research, will focus on medulloblastoma, one of the most common malignant brain tumours in children, and aims to “discover to what extent the developing brain is plastic and capable of compensating for the disturbances caused by the formation of a tumour, while maintaining its normal development and function”, as those responsible for the study say.

Miguel Seabra

24 June 2022

Greater threat, greater syntony

Researchers from the Behavioral Neuroscience Laboratory at the Champalimaud Foundation, in Portugal, strive to understand how social context influences the individual's response to threats. 

Previously, they have shown that when fruit flies in a group are faced with an inescapable threat, they lower their defences compared to when alone. They further observed that if the other flies freeze, then so will the individual; when the group starts moving again, the individual quickly follows. Being in tune with the surrounding flies seems to bring security.

21 June 2022

The search for a “liquid biopsy” to diagnose and monitor multiple myeloma is starting to pay off

A study performed by the team of haematologist Cristina João, who leads the Myeloma and Lymphoma Research Group at the Champalimaud Centre for the Unknown, suggests that it may be possible, in a near future, to diagnose and monitor the progression of multiple myeloma (MM) by simply using a blood sample. Their results were published today (21/06/2022) in the journal Frontiers in Oncology.

Esperança Ribeiro

Open Dialogue @ Insight Inside Exhibition

Open Dialogue @ Insight Inside Exhibition: 22 June, 7:30pm

 

What is the story behind each sculpture of Insight Inside exhibition? 
What inspired the artist to work with waste materials from the Champalimaud Foundation?
What is the connection between art, science and health?
 

Maria João Susano

Filipa Amorim

Berta Sousa

Subscribe to Champalimaud Research
Loading
Please wait...